Entrada Therapeutics, Inc.

TRDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001689375

SEC filings (opens in a new tab)

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Superinvestors holding TRDA, Q2 2026

See all superinvestors

No superinvestor reported holding TRDA in Q2 2026.